XML 74 R59.htm IDEA: XBRL DOCUMENT
v3.22.4

ACQUISITIONS AND OTHER ARRANGEMENTS - Celerity Pharmaceuticals, LLC Narrative (Details) - Licensing Agreements - Celerity - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2022 | Dec. 31, 2020
Acquisitions And Collaborations [Line Items] |  |
Proceeds from divestiture of product rights |  | $ 1
Loss on product divestiture arrangement | $ 54 |

X
- Definition Acquisitions and collaborations. + References No definition available. + Details
Name: | bax_AcquisitionsAndCollaborationsLineItems
Namespace Prefix: | bax_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gain (Loss) on Disposition of Product Divestiture Arrangement + References No definition available. + Details
Name: | bax_GainLossOnDispositionOfProductDivestitureArrangement
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Proceeds from Divestiture of Product Rights + References No definition available. + Details
Name: | bax_ProceedsFromDivestitureOfProductRights
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=bax_CelerityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |